Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
公司代碼PLRZ
公司名稱Polyrizon Ltd
上市日期Oct 29, 2024
CEOIzraeli (Tomer)
員工數量1
證券類型Ordinary Share
年結日Oct 29
公司地址HaTidhar St. 5
城市RA'ANANA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編- -
電話97293740120
網址https://polyrizon-biotech.com/
公司代碼PLRZ
上市日期Oct 29, 2024
CEOIzraeli (Tomer)